What does CUSIP 492515101 represent in this 13F holders report?

CUSIP 492515101 is the security identifier for KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK used to aggregate holder disclosures.

How many institutions held KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in Q4 2018?

No institutional holders were reported for KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in Q4 2018; review adjacent reporting periods for trend context.

KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / COMMON STOCK
Total 13F shares: 0
Share change: -74,335,300
Total reported value: $0
Price per share: $3.00
Number of holders: 0
Value change: -$252,722,815
Number of sells: 116

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q3 2018

Recent filing periods for CUSIP 492515101:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

Q4 2018 13F Holders as of 31 Dec 2018

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK as of Q4 2018.